M
Mersana Therapeutics D
D
MRSN
0.31370
USD
-0.03
(-7.54%)
مفتوح الان
حجم التداول
9,701
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
39,096,851
الأخبار المقالات
العنوان: Mersana Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADCplatforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.